Sign Up to Receive Your Personalised Learning Resources
CONFERENCE HUB
Per Ljungman, EBMT23: Outcomes and mortality in cytomegalovirus seropositive allogeneic stem cell transplantation patients with COVID-19
Start Learning
Sign up to view Favourites, Keep Notes and Track CME Credits
Favourites
The rationale for protein degradation and immunomodulation in RRMM: Highlighting the latest data and available clinical trials
View
IMerge Phase 3 study – Imetelstat achieving RBC-TI in lower-risk myelodysplastic syndromes: Rami Komrokji, ASH 2023
View
Mark Levis, EHA 2023: MORPHO trial of gilteritinib as post-transplant maintenance for FLT3-ITD acute myeloid leukaemia
View
Robin Foa, EBMT23: Should we transplant all patients with Philadelphia positive ALL?
View
John Mascarenhas, EHA 2023: Overview and limitations of current therapeutic options for myelofibrosis
View
Marina Kremyanskaya, EHA 2023: The REVIVE study of rusfertide in polycythaemia vera – aims and methodology
View
Anna Sureda, EBMT23: The lastest from the HARMONY Alliance and the Big Data Platform
View
Managing the practicalities of CAR T-cell therapies in patients with R/R MCL: Current considerations and future strategies
View
Optimizing outcomes of JAK inhibition in myelofibrosis: Practical considerations for the clinic
View
John Mascarenhas, EHA 2023: Phase II MANIFEST trial: Pelabresib combined with ruxolitinib for patients with myelofibrosis
View